semaglutide 0.25mg/0.5ml Wegovy 0.25 mg and reduced Ozempic 0.25 mg, 0.5 mg

Leading digital weight management solution providers already started to offer companion solutions for GLP-1 patients

Any dose changes should be discussed with a clinician based on how you respond to the medication

Most clients schedule sessions every one to two weeks

Presently, the Australian Diabetes Society (ADS) and ANZCA Perioperative Diabetes and Hyperglycaemia Guidelines (November 2022) provide the universal recommendation to withhold all non-insulin antihyperglycaemics on day of surgery, including GLP-1 agonists, with SGLT2 inhibitors to be withheld 2 days prior to surgery

Clinical discussions of this issue generally focus on indirect pathways rather than direct endocrine effects